These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients. Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342 [TBL] [Abstract][Full Text] [Related]
50. Is methotrexate an acceptable treatment in the management of idiopathic granulomatous mastitis? Akbulut S; Arikanoglu Z; Senol A; Sogutcu N; Basbug M; Yeniaras E; Yagmur Y Arch Gynecol Obstet; 2011 Nov; 284(5):1189-95. PubMed ID: 21207047 [TBL] [Abstract][Full Text] [Related]
51. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial. Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102 [TBL] [Abstract][Full Text] [Related]
52. Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register. Lie E; van der Heijde D; Uhlig T; Mikkelsen K; Kalstad S; Kaufmann C; Rødevand E; Kvien TK Ann Rheum Dis; 2011 Dec; 70(12):2103-10. PubMed ID: 21875874 [TBL] [Abstract][Full Text] [Related]
53. Randomized, placebo-controlled, crossover trial of low-dose oral methotrexate in children with extended oligoarticular or systemic arthritis. Woo P; Southwood TR; Prieur AM; Doré CJ; Grainger J; David J; Ryder C; Hasson N; Hall A; Lemelle I Arthritis Rheum; 2000 Aug; 43(8):1849-57. PubMed ID: 10943876 [TBL] [Abstract][Full Text] [Related]
54. Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials. Doyle MK; Rahman MU; Han C; Han J; Giles J; Bingham CO; Bathon J Semin Arthritis Rheum; 2009 Oct; 39(2):123-31. PubMed ID: 18823645 [TBL] [Abstract][Full Text] [Related]
55. [Long-term effects of glatiramer acetate in multiple sclerosis]. Brochet B Rev Neurol (Paris); 2008 Nov; 164(11):917-26. PubMed ID: 18790510 [TBL] [Abstract][Full Text] [Related]
56. Longterm methotrexate use in rheumatoid arthritis: 12 year followup of 460 patients treated in community practice. Wluka A; Buchbinder R; Mylvaganam A; Hall S; Harkness A; Lewis D; Littlejohn GO; Miller MH; Ryan PF J Rheumatol; 2000 Aug; 27(8):1864-71. PubMed ID: 10955325 [TBL] [Abstract][Full Text] [Related]
57. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis. Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975 [TBL] [Abstract][Full Text] [Related]
59. Prospective evaluation of treatment response and disease reversibility of paediatric localized scleroderma (morphoea) to steroids and methotrexate using multi-modal imaging. Weibel L; Theiler M; Howell KJ; Denton CP; Waelchli R; Atherton D; Woo P; Harper JI J Eur Acad Dermatol Venereol; 2020 Jul; 34(7):1609-1616. PubMed ID: 32080907 [TBL] [Abstract][Full Text] [Related]
60. Disease course and long-term outcome of juvenile localized scleroderma: Experience from a single pediatric rheumatology Centre and literature review. Martini G; Fadanelli G; Agazzi A; Vittadello F; Meneghel A; Zulian F Autoimmun Rev; 2018 Jul; 17(7):727-734. PubMed ID: 29729451 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]